Ads
related to: Patents and Dyskinesia
Search results
Neurocrine Biosciences Announces CEO Succession Plan
FOX 4 Kansas City· 1 day agoNeurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced that Kevin Gorman, Ph.D., will retire as Chief Executive Officer of Neurocrine on October 11, 2024. Kyle Gano, Ph.D., currently Neurocrine's ...